Kernicterus: Multimedia

References

1. Johnson L, Brown AK. A pilot registry for acute and chronic kernicterus in term and near-term infants. Pediatrics. Sept 1999;104:(3):736.

2. Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr. Apr 2002;140(4):396-403. [Medline].

3. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr. Oct 2000;89(10):1213-7. [Medline].

4. British Paediatric Surveillance Unit. Surveillance of severe hyperbilirubinaemia in the newborn commenced the May. BPSU Quarterly Bulletin. 2003;11(2):2.

5. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ. Sep 12 2006;175(6):587-90. [Medline].

6. McDonagh AF. Ex uno plures: the concealed complexity of bilirubin species in neonatal blood samples. Pediatrics. Sep 2006;118(3):1185-7. [Medline].

7. AAP. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. Jul 2004;114(1):297-316. [Medline].

8. [Best Evidence] Mehta S, Kumar P, Narang A. A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. J Pediatr. 2005;147 (6):781 - 5. [Medline].

9. Sanpavat S. Exchange transfusion and its morbidity in ten-year period at King Chulalongkorn Hospital. J Med Assoc Thai. May 2005;88(5):588-92. [Medline].

10. Badiee Z. Exchange transfusion in neonatal hyperbilirubinaemia: experience in Isfahan, Iran. Singapore Med J. May 2007;48(5):421-3. [Medline].

11. [Best Evidence] Gourley GR, Li Z, Kreamer BL, Kosorok MR. A controlled, randomized, double-blind trial of prophylaxis against jaundice among breastfed newborns. Pediatrics. Aug 2005;116(2):385-91. [Medline].

12. Dennery PA. Metalloporphyrins for the treatment of neonatal jaundice. Curr Opin Pediatr. Apr 2005;17(2):167-9. [Medline].

13. Kaplan M, Kaplan E, Hammerman C, et al. Post-phototherapy neonatal bilirubin rebound: a potential cause of significant hyperbilirubinaemia. Arch Dis Child. Jan 2006;91(1):31-4. [Medline].

14. Martins BM, de Carvalho M, Moreira ME, Lopes JM. Efficacy of new microprocessed phototherapy system with five high intensity light emitting diodes (Super LED). J Pediatr (Rio J). May-Jun 2007;83(3):253-8. [Medline].

15. Romagnoli C, Zecca E, Papacci P, Vento G, Girlando P, Latella C. Which phototherapy system is most effective in lowering serum bilirubin in very preterm infants?. Fetal Diagn Ther. 2006;21(2):204-9. [Medline].

16. van Kaam AH, van Beek RH, Vergunst-van Keulen JG, et al. Fibre optic versus conventional phototherapy for hyperbilirubinaemia in preterm infants. Eur J Pediatr. Feb 1998;157(2):132-7. [Medline].

17. Keren R, Bhutani VK, Luan X, Nihtianova S, Cnaan A, Schwartz JS. Identifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches. Arch Dis Child. Apr 2005;90(4):415-21. [Medline].

18. Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani VK. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics. Jan 2008;121(1):e170-9. [Medline].

19. Raghavan K, Thomas E, Patole S, Muller R. Is phototherapy a risk factor for ileus in high-risk neonates?. J Matern Fetal Neonatal Med. Aug 2005;18(2):129-31. [Medline].

20. Ahlfors CE, Wennberg RP. Bilirubin-albumin binding and neonatal jaundice. Semin Perinatol. Oct 2004;28(5):334-9. [Medline].

21. AlOtaibi SF, Blaser S, MacGregor DL. Neurological complications of kernicterus. Can J Neurol Sci. Aug 2005;32(3):311-5. [Medline].

22. Bader D, Yanir Y, Kugelman A, et al. Induction of early meconium evacuation: is it effective in reducing the level of neonatal hyperbilirubinemia?. Am J Perinatol. Aug 2005;22(6):329-33. [Medline].

23. Barefield ES, Dwyer MD, Cassady G. Association of patent ductus arteriosus and phototherapy in infants weighting less than 1000 grams. J Perinatol. Sep-Oct 1993;13(5):376-80. [Medline].

24. Bhutani VK, Donn SM, Johnson LH. Risk management of severe neonatal hyperbilirubinemia to prevent kernicterus. Clin Perinatol. 2005;32 (1):125 - 39, vii. [Medline].

25. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. Jan 1999;103(1):6-14. [Medline]. [Full Text].

26. Bhutani VK, Johnson LH, Jeffrey Maisels M, et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol. Oct 2004;24(10):650-62. [Medline].

27. Cashore WJ. Bilirubin and jaundice in the micropremie. Clin Perinatol. Mar 2000;27(1):171-9, vii. [Medline].

28. Drummond GS, Kappas A. Chemoprevention of severe neonatal hyperbilirubinemia. Semin Perinatol. Oct 2004;28(5):365-8. [Medline].

29. Gartner LM. Neonatal jaundice. Pediatr Rev. Nov 1994;15(11):422-32. [Medline].

30. Juretschke LJ. Kernicterus: still a concern. Neonatal Netw. Mar-Apr 2005;24(2):7-19. [Medline].

31. Kaplan M, Hammerman C. Understanding severe hyperbilirubinemia and preventing kernicterus: adjuncts in the interpretation of neonatal serum bilirubin. Clin Chim Acta. Jun 2005;356(1-2):9-21. [Medline].

32. Kumral A, Genc S, Genc K, et al. Hyperbilirubinemic serum is cytotoxic and induces apoptosis in murine astrocytes. Biol Neonate. 2005;87(2):99-104. [Medline].

33. MacMahon JR, Stevenson DK, Oski FA. Physiologic jaundice. In: Taeusch, Ballards, eds. Avery's Disease of the Newborn. 7^th ed. Philadelphia, PA: Saunders; 1998:1003-7.

34. Maisels MJ. Jaundice. In: Avery, Fletcher, eds. Neonatology, Pathophysiology and Management of the Newborn. 5^th ed. Philadelphia, PA: Lippincott; 1999:765-819.

35. Petersen JR, Okorodudu AO, Mohammad AA, et al. Association of transcutaneous bilirubin testing in hospital with decreased readmission rate for hyperbilirubinemia. Clin Chem. 2005;51 (3):481 - 2. [Medline]. [Full Text].

36. Pezzati M, Biagiotti R, Vangi V, et al. Changes in mesenteric blood flow response to feeding: conventional versus fiber-optic phototherapy. Pediatrics. Feb 2000;105(2):350-3. [Medline]. [Full Text].

37. Rubegni P, Cevenini G, Sbano P, et al. Cutaneous colorimetric evaluation of serum concentrations of bilirubin in healthy term neonates: a new methodological approach. Skin Res Technol. Feb 2005;11(1):70-5. [Medline].

38. Sanpavat S, Nuchprayoon I. Noninvasive transcutaneous bilirubin as a screening test to identify the need for serum bilirubin assessment. J Med Assoc Thai. Oct 2004;87(10):1193-8. [Medline].

39. Shapiro SM. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol. Jan 2005;25(1):54-9. [Medline].

40. Taketomo CK, Hodding JH, Draus DM. Pediatric Dosage Handbook. 10^th ed. Cleveland, OH: Lexi-Comp, Inc; 2003.

41. Volpe JJ. Bilirubin and Brain Injury: Neurology of the Newborn. 3^rd ed. Philadelphia, PA: WB Saunders; 1995:490-514.

42. Watchko JF. Vigintiphobia revisited. Pediatrics. Jun 2005;115(6):1747-53. [Medline].

43. Willems WA, van den Berg LM, de Wit H, Molendijk A. Transcutaneous bilirubinometry with the Bilicheck in very premature newborns. J Matern Fetal Neonatal Med. Oct 2004;16(4):209-14. [Medline].

Further Reading

Keywords

kernicterus, acute bilirubin encephalopathy, chronic postkernicteric bilirubin encephalopathy, chronic bilirubin encephalopathy, profound pathologic hyperbilirubinemia, bilirubin-induced neurologic dysfunction, BIND, jaundice, hemolytic disease, glucose-6-phosphate dehydrogenase deficiency, hereditary spherocytosis, retrocollis, opisthotonus, athetosis, chorea, hearing loss, delayed language acquisition, birth trauma, Crigler-Najjar syndrome, polycythemia, smoking, hemolytic disease of the newborn, pyruvate kinase deficiency, thalassemia, cephalohematoma, subgaleal hemorrhage, peripheral ecchymoses, hypoalbuminemia, liver transplantation, Arias syndrome, Gilbert syndrome, galactosemia, hypothyroidism, acidosis, breastfeeding jaundice, breast milk jaundice

Contributor Information and Disclosures

Author

Shelley C Springer, MD, MBA, MSc, FAAP, JD LS-3, Clinical Instructor, Department of Pediatrics, University of Wisconsin; Neonatologist, Pediatrix Medical Group; Assistant Clinical Professor, Department of Pediatrics, University of North Texas Science Center; Assistant Clinical Professor, Department of Pediatrics, Texas A & M University
Shelley C Springer, MD, MBA, MSc, FAAP, JD LS-3 is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, and Minnesota Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

David J Annibale, MD, Associate Professor, Director of Neonatology, Director of Fellowship Training Program in Neonatal-Perinatal Medicine, Department of Pediatrics, Medical University of South Carolina
David J Annibale, MD is a member of the following medical societies: American Academy of Pediatrics and National Perinatal Association
Disclosure: Nothing to disclose.

Medical Editor

Oussama Itani, MD, FAAP, FACN, Clinical Associate Professor of Pediatrics and Human Development, Michigan State University; Medical Director, Department of Neonatology, Borgess Medical Center
Oussama Itani, MD, FAAP, FACN is a member of the following medical societies: American Academy of Pediatrics, American College of Nutrition, American College of Physician Executives, and American Heart Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

David A Clark, MD, Chairman, Professor, Department of Pediatrics, Albany Medical College
David A Clark, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Pediatric Society, Christian Medical & Dental Society, Medical Society of the State of New York, New York Academy of Sciences, and Society for Pediatric Research
Disclosure: Nothing to disclose.

CME Editor

Carol L Wagner, MD, Professor of Pediatrics, Medical University of South Carolina
Carol L Wagner, MD is a member of the following medical societies: American Academy of Pediatrics, American Chemical Society, American Medical Women's Association, American Public Health Association, American Society for Bone and Mineral Research, American Society for Clinical Nutrition, Massachusetts Medical Society, National Perinatal Association, and Society for Pediatric Research
Disclosure: Nothing to disclose.

Chief Editor

Ted Rosenkrantz, MD, Professor, Departments of Pediatrics and Obstetrics/Gynecology, Division of Neonatal-Perinatal Medicine, University of Connecticut School of Medicine
Ted Rosenkrantz, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Pediatric Society, Connecticut State Medical Society, Eastern Society for Pediatric Research, and Society for Pediatric Research
Disclosure: Nothing to disclose.